Company / Working Capital per Share
Compass Therapeutics, Inc. Working Capital per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.90
FY2024
5-year range
$0.90 / $2.17
FY2020-FY2024
Trend
-21.4%
vs FY2023
Sector context
#182 of 210
Health Care
What the data says
Compass Therapeutics, Inc.'s working capital per share of $0.90 is lower than 87% of companies in the Health Care sector (FY2024). Working Capital per Share has declined for 3 consecutive years, from $2.17 in FY2021 to $0.90 in FY2024.
Based on SEC 10-K filings.
0.90 in FY2024 with a 5-year CAGR of -18.2%.
Declined from $1.41 to $0.90 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -25.5%
- 5-Year CAGR
- -18.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 210This company $0.90 Sector average $146.71
▼
-99.4% below sector average
Key checks
Key Insights
- Compass Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 21.4% year-over-year.
- Ranks #182 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.90 | -21.4% |
| FY2023 | $1.14 | -19.1% |
| FY2022 | $1.41 | -34.8% |
| FY2021 | $2.17 | +66.6% |
| FY2020 | $1.30 | -46.9% |
| FY2019 | $2.45 | +35605.8% |
| FY2018 | -$0.01 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026